Redefining Haemostasis in Minimally Invasive Surgery: Surgi-ORC® Powder
Redefining Haemostasis in Minimally Invasive Surgery: Surgi-ORC® Powder
Minimally invasive surgical (MIS) like endoscopic and laparoscopic surgery use a small camera-equipped tube to treat or diagnose internal conditions without large incisions. In these procedures, achieving haemostasis is essential. Even minor bleeding can obscure visibility, slow the operation, increase transfusion needs and if bleeding uncontrolled, place the patient at serious risk.1
This is where Surgi-ORC®, an effective haemostat, helps control oozing, reduces blood loss. Keep the field clear for safer and smoother procedures.
What is Surgi-ORC® Powder?
Surgi-ORC® Powder is a sterile, natural, plant-based absorbable oxidized regenerated cellulose (ORC) endoscopic powder designed to achieve effective haemostasis when applied directly to bleeding tissue or site. The powder format allows uniform dispersion and easy application in endoscopic, laparoscopic, or open surgical procedures.
Fig 1: Surgi-ORC® endoscopic powder
What makes Surgi-ORC® Powder special?
How does Surgi-ORC® Powder work?
Surgi-ORC® Mechanism: Upon contact with blood, Surgi-ORC® endoscopic powder helps to control capillary, venous and small arterial haemorrhage.
What are the key benefits for surgeons?
Real-world clinical evidence and applications:
Real-world evidence
In a prospective, open-label, single-arm multicenter trial involving 103 patients, SURGICEL® Powder achieved haemostasis rates of 77.7%, 87.4%, and 92.2% at 3, 5, and 10 minutes, demonstrating safety, effectiveness, and ease of use across various surgical procedures.4
Broad clinical applications of ORC Powder2-4
| Parameters | Details / Findings | Significance |
| Range of Surgical Specialties | Used across urological, abdominal, gynecological, and cardiothoracic surgeries3,4 | Demonstrates wide applicability across surgical fields |
| Type of Procedures | Effective in both open and laparoscopic/thoracoscopic procedures | Suitable for minimally invasive and conventional surgeries |
| Type of Bleeding Controlled | Capillary, venous, or small arterial bleeding; mild to moderate severity | Versatile for various bleeding intensities |
| Tissue Types Treated | Parenchymal, connective, loose areolar and others | Works effectively on broad or raw tissue surfaces |
| Difficult Anatomical Areas | Useful in regions near nerves, vessels, or uneven tissue topography | Ensures haemostasis where cautery/suturing are unsafe |
| Endoscopic/ Laparoscopic Powder Use | Delivered precisely using SURGICEL®-P Endoscopic Applicator4 | Allows easy haemostasis in confined surgical fields |
Conclusion
Surgi-ORC® Powder makes bleeding control in MIS simpler and more reliable. By providing quick haemostasis, improving visibility and demonstrating strong safety in clinical use. It gives surgeons greater confidence and helps patients recover faster and more safely.
References
- Ricciardi S, Patel AJ, Alunni Fegatelli D, Volpi S, Femia F, Petrella L, Bille A, Cardillo G. Absorbable Powder Haemostat Use in Minimally Invasive Thoracic Surgery. Journal of Clinical Medicine. 2024 Dec 27;14(1):8
- Kanagal, Deepa & Rao, Karthik & Gathoga, Peter & Moharana, Kabir & Patil, Rajas & Jaiswal, Purva & AP, Venkataraman. (2025). Biomaterial-Based Hemostasis: A Review of the Clinical and Functional Versatility of Oxidized Regenerated Cellulose. Cureus. 10.7759/cureus.94602.
- Auslands K, Kocane E, Bergfelde E, Valeinis E, Dolgopolova J, Aksiks J, Aksiks I. Evaluation of the Performance of StypCelTM Absorbable Hemostat for Intraoperative Hemorrhage Control in Neurosurgery: A Multicenter, Single-Arm Study in Riga, Latvia. Medicina. 2025 Oct 16;61(10):1862.
- Al-Attar N, de Jonge E, Kocharian R, Ilie B, Barnett E, Berrevoet F. Safety and hemostatic effectiveness of SURGICEL® powder in mild and moderate intraoperative bleeding. Clinical and Applied Thrombosis/Hemostasis. 2023 Jul;29:10760296231190376.
